1 completed, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow Gut Microbiota: new trials by email Literature Review of Gut Microbiota trials Research Report on Gut Microbiota
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Continuous Treatment With Rifaximin and Probiotics on the Gut Microbiota of Patients With IBS-D Rifaximin, Probiotic Formula, Placebo oral tablet - IBS - Irritable Bowel Syndrome, Gut Microbiota | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 240 | 2020-05-10 | 2020-07-28 |
| Lactobacillus Rhamnosus GG: Interaction With Human Microbiota and Immunity Casein hydrolysate added with LGG, Infants drink casein hydrolysate without LGG - Gut Microbiota, Skin Microbiota | Phase 4 | Completed | Turku University Hospital | 40 | 2007-03-01 | 2010-06-22 |
Dermatitis, Atopic (1) · Irritable Bowel Syndrome (1)
Colonic Diseases (1) · Colonic Diseases, Functional (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Dermatitis (1) · Digestive System Diseases (1) · Gastrointestinal Diseases (1) · Genetic Diseases, Inborn (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Intestinal Diseases (1) · Skin Diseases (1) · Skin Diseases, Eczematous (1) · Skin Diseases, Genetic (1) · Skin and Connective Tissue Diseases (1)
Rifaximin (1)
Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Turku University Hospital (1)
China (1) · Finland (1)